Zheng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zheng Zhang has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
Rui Peng
Department of Bioinformatics, Chongqing Medical University, Chongqing, China
23 shared publications- Yan Sun
Department of Nephrology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
16 shared publications Handeng Liu
Laboratory of Tissue and Cell Biology, Experimental Teaching and Management Center, Chongqing Medical University, Chongqing, China
15 shared publications- Xiaohui Liao
The Second Affiliated Hospital, Chongqing Medical University
14 shared publications Huimin Peng
Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, China
10 shared publicationsTianhui Wu
Department of Cell Biology and Genetics, Basic Medical College, Chongqing Medical University, Chongqing, China
9 shared publications
Latest Publications
- Open Access
- 28 August 2026
- Published by Springer Nature in Research Square
Uracil-DNA glycosylase 1 mitigates acute kidney injury inflammation by maintaining mtDNA homeostasis
Acute kidney injury (AKI) is a common clinical syndrome that is caused by multiple factors, such as ischemia-reperfusion and nephrotoxic drugs. Current treatment strategies for AKI are focused on supportive therapy, and thus, there remains a lack of effective etiological therapies. Mitochondrial dysfunction, which leads to mitochondrial DNA (mtDNA) breaks and triggers cGAS-STING inflammatory responses, has been shown to play a significant role in the progression of AKI. Here, we observed a reduced inflammatory response during AKI in Sting-/- mice prompting us to examine the role of mtDNA in inflammation further. The mitochondrial protein Uracil-DNA glycosylase 1 (UNG1) is a key component of mtDNA base excision repair (BER) and maintains mitochondrial genome stability. Recent studies have shown that UNG-mediated BER is associated with various diseases; however, the role of UNG1 in kidney disease remains under-reported. In this study, we confirmed mitochondrial dysfunction in both in vivo and in vitro models of AKI and identified a mtDNA-mediated inflammatory response. Our results indicate that overexpression of UNG1 in mice significantly alleviates renal dysfunction and inflammatory responses induced by ischemia-reperfusion and cisplatin. Concurrently, overexpression of UNG1 in cells was found to reduce mtDNA breaks and leakage, and attenuated mtDNA-mediated inflammatory responses. Through mass spectrometry, we identified a potential binding interaction between the mtDNA nucleoid-associated protein single-stranded DNA binding protein 1 (SSBP1) and UNG1. This binding affinity was confirmed through molecular docking, and Co-IP. In addition, using oligomerization assays, we showed that UNG1 promoted SSBP1 dimer/tetramer formation, while ChIP assays further verified that UNG1 regulated SSBP1-mtDNA binding. Finally, the protective effects of UNG1 were also observed in AKI Sting-/- mice. In conclusion, our study shows that UNG1 effectively alleviates AKI by promoting SSBP1-mediated nucleoid formation, suggesting that UNG1 may be a potential therapeutic target for managing and treating AKI.
- 28 August 2026
- Published by Springer Nature in Research Square
Open AccessUracil-DNA glycosylase 1 mitigates acute kidney injury inflammation by maintaining mtDNA homeostasis
Acute kidney injury (AKI) is a common clinical syndrome that is caused by multiple factors, such as ischemia-reperfusion and nephrotoxic drugs. Current treatment strategies for AKI are focused on supportive therapy, and thus, there remains a lack of effective etiological therapies. Mitochondrial dysfunction, which leads to mitochondrial DNA (mtDNA) breaks and triggers cGAS-STING inflammatory responses, has been shown to play a significant role in the progression of AKI. Here, we observed a reduced inflammatory response during AKI in Sting-/- mice prompting us to examine the role of mtDNA in inflammation further. The mitochondrial protein Uracil-DNA glycosylase 1 (UNG1) is a key component of mtDNA base excision repair (BER) and maintains mitochondrial genome stability. Recent studies have shown that UNG-mediated BER is associated with various diseases; however, the role of UNG1 in kidney disease remains under-reported. In this study, we confirmed mitochondrial dysfunction in both in vivo and in vitro models of AKI and identified a mtDNA-mediated inflammatory response. Our results indicate that overexpression of UNG1 in mice significantly alleviates renal dysfunction and inflammatory responses induced by ischemia-reperfusion and cisplatin. Concurrently, overexpression of UNG1 in cells was found to reduce mtDNA breaks and leakage, and attenuated mtDNA-mediated inflammatory responses. Through mass spectrometry, we identified a potential binding interaction between the mtDNA nucleoid-associated protein single-stranded DNA binding protein 1 (SSBP1) and UNG1. This binding affinity was confirmed through molecular docking, and Co-IP. In addition, using oligomerization assays, we showed that UNG1 promoted SSBP1 dimer/tetramer formation, while ChIP assays further verified that UNG1 regulated SSBP1-mtDNA binding. Finally, the protective effects of UNG1 were also observed in AKI Sting-/- mice. In conclusion, our study shows that UNG1 effectively alleviates AKI by promoting SSBP1-mediated nucleoid formation, suggesting that UNG1 may be a potential therapeutic target for managing and treating AKI.
- Open Access
- 7 July 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
LncPTEC mediated homocysteine accumulation elevates oxidative stress via UBQLN1-dependent MTHFD1 ubiquitination in DKD
Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease and chronic kidney disease. Oxidative stress, a key driver of renal fibrosis and a hallmark of DKD pathological changes, has been extensively studied for its role in DKD progression. However, its specific mechanisms remain unclear. Here, we show that homocysteine (Hcy) accumulation in proximal tubular epithelial cells (PTECs) is a significant contributor to mitochondrial oxidative stress in DKD. Through single-cell RNA sequencing (scRNA-seq) screening, we identify lncPTEC, a DKD-associated long non-coding RNA (lncRNA) from the PTEC cluster. Notably, we find that upregulated lncPTEC correlates with elevated albuminuria in DKD patients and exacerbates mitochondrial oxidative stress, epithelial-mesenchymal transition (EMT) and renal tubular fibrosis both in vitro and in vivo. Mechanistically, lncPTEC is transcriptionally upregulated by the transcription factor specificity protein 1 (SP1) under hyperglycemic conditions. Furthermore, lncPTEC directly interacts with the established key factor of Hcy metabolism, methylenetetrahydrofolate dehydrogenase 1 (MTHFD1), promoting its ubiquitination and degradation via the ubiquitination-related protein UBQLN1. This process leads to Hcy accumulation, mitochondrial oxidative stress, and subsequent DKD progression. Hence, our findings elucidate the role of the lncPTEC/MTHFD1 axis in Hcy-mediated mitochondrial oxidative stress, offering potential diagnostic biomarkers and therapeutic targets for DKD.
- 7 July 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Open AccessLncPTEC mediated homocysteine accumulation elevates oxidative stress via UBQLN1-dependent MTHFD1 ubiquitination in DKD
Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease and chronic kidney disease. Oxidative stress, a key driver of renal fibrosis and a hallmark of DKD pathological changes, has been extensively studied for its role in DKD progression. However, its specific mechanisms remain unclear. Here, we show that homocysteine (Hcy) accumulation in proximal tubular epithelial cells (PTECs) is a significant contributor to mitochondrial oxidative stress in DKD. Through single-cell RNA sequencing (scRNA-seq) screening, we identify lncPTEC, a DKD-associated long non-coding RNA (lncRNA) from the PTEC cluster. Notably, we find that upregulated lncPTEC correlates with elevated albuminuria in DKD patients and exacerbates mitochondrial oxidative stress, epithelial-mesenchymal transition (EMT) and renal tubular fibrosis both in vitro and in vivo. Mechanistically, lncPTEC is transcriptionally upregulated by the transcription factor specificity protein 1 (SP1) under hyperglycemic conditions. Furthermore, lncPTEC directly interacts with the established key factor of Hcy metabolism, methylenetetrahydrofolate dehydrogenase 1 (MTHFD1), promoting its ubiquitination and degradation via the ubiquitination-related protein UBQLN1. This process leads to Hcy accumulation, mitochondrial oxidative stress, and subsequent DKD progression. Hence, our findings elucidate the role of the lncPTEC/MTHFD1 axis in Hcy-mediated mitochondrial oxidative stress, offering potential diagnostic biomarkers and therapeutic targets for DKD.
- Open Access
- 15 April 2026
- Published by Elsevier in Journal of Advanced Research
SFRP2 aggravates diabetic kidney disease by repressing the renal protective CH25H/25-hydroxycholesterol axis in mesangial cells
- 15 April 2026
- Published by Elsevier in Journal of Advanced Research
Open AccessSFRP2 aggravates diabetic kidney disease by repressing the renal protective CH25H/25-hydroxycholesterol axis in mesangial cells
- 2 February 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Vol. 1869 (1) , 195138
MOV10-mediated alternative splicing regulates mesangial cell proliferation in diabetic kidney disease
- 2 February 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Vol. 1869 (1) , 195138
MOV10-mediated alternative splicing regulates mesangial cell proliferation in diabetic kidney disease
- Open Access
- 22 January 2026
- Published by Springer Nature in Inflammation
- Vol. 49 (1)
Integrated Transcriptomic Analysis Identifies TAP1 as a Key Regulator of PANoptosis in Diabetic Kidney Disease Tubular Injury
Tubular injury is a key driver of diabetic kidney disease (DKD) progression. However, the involvement and regulatory mechanisms of PANoptosis in diabetic tubular injury remain poorly defined. Utilizing transcriptomic datasets from DKD renal tubules, we identified differentially expressed genes (DEGs) through limma analysis and co-expression modules via weighted gene co-expression network analysis (WGCNA). These findings were intersected with a comprehensive PANoptosis-related gene set. Hub genes were further prioritized using machine learning algorithms, including LASSO regression and random forest. Validation was conducted through the Nephroseq database, single-cell RNA sequencing (scRNA-seq) analysis and experimental studies in high glucose-treated tubular cells, DKD mice, and human DKD biopsies. Furthermore, functional enrichment and immune infiltration analyses were performed to elucidate biological implications. We revealed 1,624 DEGs and two key WGCNA modules significantly associated with DKD. Among 31 PANoptosis-related DEGs, machine learning prioritized three hub genes (TAP1, CASP1, PRKX), all of which were significantly upregulated in DKD and exhibited negative correlations with glomerular filtration rate. Functional analyses linked these hub genes to inflammatory and immune responses and scRNA-seq data confirmed their overexpression in proximal tubular cells. Moreover, experimental validation consistently demonstrated TAP1 upregulation in tubular cells under high glucose conditions, kidney tissues from DKD mouse models and human DKD biopsy samples. Our integrated analysis identifies TAP1 as a crucial regulator of PANoptosis in injured renal tubules of DKD, providing novel mechanistic insights into the pathogenesis of tubular injury and a potential therapeutic target for future research.
- 22 January 2026
- Published by Springer Nature in Inflammation
- Vol. 49 (1)
Open AccessIntegrated Transcriptomic Analysis Identifies TAP1 as a Key Regulator of PANoptosis in Diabetic Kidney Disease Tubular Injury
Tubular injury is a key driver of diabetic kidney disease (DKD) progression. However, the involvement and regulatory mechanisms of PANoptosis in diabetic tubular injury remain poorly defined. Utilizing transcriptomic datasets from DKD renal tubules, we identified differentially expressed genes (DEGs) through limma analysis and co-expression modules via weighted gene co-expression network analysis (WGCNA). These findings were intersected with a comprehensive PANoptosis-related gene set. Hub genes were further prioritized using machine learning algorithms, including LASSO regression and random forest. Validation was conducted through the Nephroseq database, single-cell RNA sequencing (scRNA-seq) analysis and experimental studies in high glucose-treated tubular cells, DKD mice, and human DKD biopsies. Furthermore, functional enrichment and immune infiltration analyses were performed to elucidate biological implications. We revealed 1,624 DEGs and two key WGCNA modules significantly associated with DKD. Among 31 PANoptosis-related DEGs, machine learning prioritized three hub genes (TAP1, CASP1, PRKX), all of which were significantly upregulated in DKD and exhibited negative correlations with glomerular filtration rate. Functional analyses linked these hub genes to inflammatory and immune responses and scRNA-seq data confirmed their overexpression in proximal tubular cells. Moreover, experimental validation consistently demonstrated TAP1 upregulation in tubular cells under high glucose conditions, kidney tissues from DKD mouse models and human DKD biopsy samples. Our integrated analysis identifies TAP1 as a crucial regulator of PANoptosis in injured renal tubules of DKD, providing novel mechanistic insights into the pathogenesis of tubular injury and a potential therapeutic target for future research.
- 22 January 2026
- Published by Elsevier in Metabolism
- Vol. 177, 156510
HMGCS2 desuccinylation modulates acetoacetate to drive tubule-macrophage inflammatory crosstalk in diabetic kidney disease
- 22 January 2026
- Published by Elsevier in Metabolism
- Vol. 177, 156510
HMGCS2 desuccinylation modulates acetoacetate to drive tubule-macrophage inflammatory crosstalk in diabetic kidney disease
- 18 December 2025
- Published by Elsevier in Biomaterials
- Vol. 329, 123933
Sequential-targeting nanomedicine protects against acute kidney injury by modulating calcium influx and scavenging reactive oxygen species
- 18 December 2025
- Published by Elsevier in Biomaterials
- Vol. 329, 123933
Sequential-targeting nanomedicine protects against acute kidney injury by modulating calcium influx and scavenging reactive oxygen species
- 5 June 2025
- Published by Springer Nature in Acta Diabetologica
- Vol. 62 (11) , 1915-1927
NF-κB p65 mediated lnc-Traf3ip2 exacerbates renal fibrosis in diabetic kidney disease
Aims Diabetic kidney disease (DKD) is the predominant type of end-stage renal disease. The fibrotic response in glomerular mesangial cells (MCs) acts as an initial injury during DKD progression, but the molecular mechanism remains to be explored. Here, this present study aimed to investigate the role of NF-κB p65 mediated long noncoding RNA (lncRNA) lnc-Traf3ip2 in renal fibrosis and DKD progression. Methods The different expressions of lncRNAs in renal tissues of db/db DKD mice (n = 3) and db/dm controls (n = 3) were screened by scRNA-seq and RNA-seq. Plasma of DKD patients (n = 40) and renal tissues of DKD mice (n = 35) and their controls were further used to examine the expressions of lnc-Traf3ip2. Moreover, the relationship between the expression of lnc-Traf3ip2 and indexes of kidney function was also analyzed by Pearson correlation coefficient analysis. Furthermore, the biological functions of lnc-Traf3ip2 in mesangial cell fibrosis and renal injury were investigated by qRT-PCR, western blot and immunofluorescence in DKD in vivo and in vitro. Finally, the dual-luciferase reporter assay and ChIP were performed to investigate the regulatory mechanism of lnc-Traf3ip2 transcription. Results In our study, the results of scRNA-seq, RNA-seq and qRT-PCR revealed that lnc-Traf3ip2, which was highly expressed in mesangial cells and upregulated in renal tissues of DKD mice and the plasma of DKD patients. Data also showed lnc-Traf3ip2 was positively correlated with UACR in DKD. Moreover, overexpression of lnc-Traf3ip2 could promote fibrosis of MCs in vitro, whereas silencing lnc-Traf3ip2 alleviated MCs fibrosis under high glucose condition. Additionally, lnc-Traf3ip2 knockdown alleviated renal fibrosis in DKD mice. Mechanistically, transcription factor NF-κB subunit p65 could promote the expression of lnc-Traf3ip2 via directly binding to the promoter of lnc-Traf3ip2. Conclusions Taken together, our data suggest the role of lnc-Traf3ip2 in fibrogenic factor in DKD induced by transcription factor NF-κB p65 and identified it as an therapeutic target for DKD.
- 5 June 2025
- Published by Springer Nature in Acta Diabetologica
- Vol. 62 (11) , 1915-1927
NF-κB p65 mediated lnc-Traf3ip2 exacerbates renal fibrosis in diabetic kidney disease
Aims Diabetic kidney disease (DKD) is the predominant type of end-stage renal disease. The fibrotic response in glomerular mesangial cells (MCs) acts as an initial injury during DKD progression, but the molecular mechanism remains to be explored. Here, this present study aimed to investigate the role of NF-κB p65 mediated long noncoding RNA (lncRNA) lnc-Traf3ip2 in renal fibrosis and DKD progression. Methods The different expressions of lncRNAs in renal tissues of db/db DKD mice (n = 3) and db/dm controls (n = 3) were screened by scRNA-seq and RNA-seq. Plasma of DKD patients (n = 40) and renal tissues of DKD mice (n = 35) and their controls were further used to examine the expressions of lnc-Traf3ip2. Moreover, the relationship between the expression of lnc-Traf3ip2 and indexes of kidney function was also analyzed by Pearson correlation coefficient analysis. Furthermore, the biological functions of lnc-Traf3ip2 in mesangial cell fibrosis and renal injury were investigated by qRT-PCR, western blot and immunofluorescence in DKD in vivo and in vitro. Finally, the dual-luciferase reporter assay and ChIP were performed to investigate the regulatory mechanism of lnc-Traf3ip2 transcription. Results In our study, the results of scRNA-seq, RNA-seq and qRT-PCR revealed that lnc-Traf3ip2, which was highly expressed in mesangial cells and upregulated in renal tissues of DKD mice and the plasma of DKD patients. Data also showed lnc-Traf3ip2 was positively correlated with UACR in DKD. Moreover, overexpression of lnc-Traf3ip2 could promote fibrosis of MCs in vitro, whereas silencing lnc-Traf3ip2 alleviated MCs fibrosis under high glucose condition. Additionally, lnc-Traf3ip2 knockdown alleviated renal fibrosis in DKD mice. Mechanistically, transcription factor NF-κB subunit p65 could promote the expression of lnc-Traf3ip2 via directly binding to the promoter of lnc-Traf3ip2. Conclusions Taken together, our data suggest the role of lnc-Traf3ip2 in fibrogenic factor in DKD induced by transcription factor NF-κB p65 and identified it as an therapeutic target for DKD.
- 25 April 2025
- Published by Wiley in The FEBS Journal
- Vol. 292 (19) , 5130-5150
Augmenter of liver regeneration (ALR) can regulate iron homeostasis through the INOS/NO/SLC39A14 pathway to reduce ferroptosis in acute kidney injury
Acute kidney injury (AKI) is a complex clinical syndrome that affects approximately 13.3 million people worldwide each year. Although ferroptosis has been implicated in the pathological progression of AKI, the underlying mechanisms remain elusive. Augmenter of liver regeneration (ALR) plays a role in apoptosis, autophagy and oxidative stress induction in renal tubular epithelial cells; however, the specific mechanisms through which ALR is involved in AKI are unclear. The present study investigated the effects of ALR on regulating iron uptake and ferroptosis in AKI under in vivo and in vitro conditions. Renal tubular epithelial cell‐specific Alr knockout (AlrKO) mice and ischaemia/reperfusion (I/R)‐induced AKI in vivo models were generated. ALR overexpression and hypoxia/reoxygenation (H/R)‐induced AKI in vitro models were generated using human renal tubular epithelial cells. The effects of ALR on ferroptosis and kidney function in AKI were investigated through in vitro and in vivo studies involving biochemical analysis, RT‐qPCR, western blotting assay, immunofluorescence assay, and transmission electron microscopy. Transcriptome sequencing, iron homeostasis, and inducible nitric oxide synthase (iNOS)/nitric oxide (NO) synthesis detection were performed to investigate the mechanisms through which ALR affects AKI. Loss‐of‐function experiments revealed that kidney tubule‐specific Alr knockout in mice exacerbated iron uptake, ferroptosis, and acute kidney I/R injury. Mechanistically, we found that ALR could regulate iron homeostasis through the iNOS/NO/Solute carrier family 39 member 14 (SLC39A14) pathway to reduce ferroptosis in AKI. The results of this study reveal a previously undescribed function of ALR in iron homeostasis and ferroptosis in AKI, and suggest that targeting ALR could be a potential treatment option for AKI.
- 25 April 2025
- Published by Wiley in The FEBS Journal
- Vol. 292 (19) , 5130-5150
Augmenter of liver regeneration (ALR) can regulate iron homeostasis through the INOS/NO/SLC39A14 pathway to reduce ferroptosis in acute kidney injury
Acute kidney injury (AKI) is a complex clinical syndrome that affects approximately 13.3 million people worldwide each year. Although ferroptosis has been implicated in the pathological progression of AKI, the underlying mechanisms remain elusive. Augmenter of liver regeneration (ALR) plays a role in apoptosis, autophagy and oxidative stress induction in renal tubular epithelial cells; however, the specific mechanisms through which ALR is involved in AKI are unclear. The present study investigated the effects of ALR on regulating iron uptake and ferroptosis in AKI under in vivo and in vitro conditions. Renal tubular epithelial cell‐specific Alr knockout (AlrKO) mice and ischaemia/reperfusion (I/R)‐induced AKI in vivo models were generated. ALR overexpression and hypoxia/reoxygenation (H/R)‐induced AKI in vitro models were generated using human renal tubular epithelial cells. The effects of ALR on ferroptosis and kidney function in AKI were investigated through in vitro and in vivo studies involving biochemical analysis, RT‐qPCR, western blotting assay, immunofluorescence assay, and transmission electron microscopy. Transcriptome sequencing, iron homeostasis, and inducible nitric oxide synthase (iNOS)/nitric oxide (NO) synthesis detection were performed to investigate the mechanisms through which ALR affects AKI. Loss‐of‐function experiments revealed that kidney tubule‐specific Alr knockout in mice exacerbated iron uptake, ferroptosis, and acute kidney I/R injury. Mechanistically, we found that ALR could regulate iron homeostasis through the iNOS/NO/Solute carrier family 39 member 14 (SLC39A14) pathway to reduce ferroptosis in AKI. The results of this study reveal a previously undescribed function of ALR in iron homeostasis and ferroptosis in AKI, and suggest that targeting ALR could be a potential treatment option for AKI.